Now showing items 1-5 of 5

    • Immunotherapy in the Management of Lung Cancer 

      Tasnim, Humayra (Brac University, 2021-11)
      Among all the major cancer types, lung cancer is one of the most common as it holds a higher percentage of cancer related mortality and treating lung cancer is yet a challenge. Chemotherapy, radiation therapy, surgery ...
    • Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer 

      Rahman, Tasnim (Brac University, 2023-03)
      In spite of recent developments in cancer therapy that are specifically targeted, a frightening number of individuals still pass away every year from lung cancer around the world. Because of this, we decided to focus our ...
    • Potential of liposomes for the treatment of lung cancer- a review 

      Mim, Shanzida (Brac University, 2023-01)
      Lung cancer is the leading cause of all cancer deaths worldwide among both men and women with symptoms of cough, airway obstruction and hemoptysis. Lung cancer can be divided into two subtypes which are known as small cell ...
    • A review on recent advances in drugs for lung cancer treatment 

      Noor, Fouzia (Brac University, 2023-02)
      One of the predominant reasons for cancer-related fatalities worldwide is lung cancer. Existing drugs in the therapeutic landscape though beneficial are linked with various limitations. Overcoming these posed a major ...
    • A review on targeted therapies for lung cancer 

      Ashraf, Anushey (Brac University, 2022-10)
      Lung cancer is one of the leading causes of cancer related deaths. The malignancy is marked by a bleak prognosis and poor clinical result, owing primarily to advanced stage at diagnosis, imposing a significant cost on ...